Hcw Biologics Inc (HCWB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -2,844 | -5,802 | -7,863 | -5,154 |
| Depreciation Amortization | 159 | 573 | 432 | 306 |
| Accounts receivable | 1,200 | N/A | N/A | N/A |
| Other Working Capital | 1,763 | -5,247 | 537 | 703 |
| Other Operating Activity | -1,767 | 45 | 0 | 0 |
| Operating Cash Flow | $-1,490 | $-10,431 | $-6,894 | $-4,145 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -23 | -187 | -150 | -45 |
| Investing Cash Flow | $-23 | $-187 | $-150 | $-45 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 13 | N/A | 3 | 2 |
| Other Financing Activity | -100 | 11,718 | 6,168 | 0 |
| Financing Cash Flow | $-87 | $11,718 | $6,171 | $2 |
| Beginning Cash Position | 8,456 | 7,356 | 7,356 | 7,356 |
| End Cash Position | 6,856 | 8,456 | 6,483 | 3,168 |
| Net Cash Flow | $-1,600 | $1,100 | $-873 | $-4,187 |
| Free Cash Flow | ||||
| Operating Cash Flow | -1,490 | -10,431 | -6,894 | -4,145 |
| Capital Expenditure | -23 | N/A | -150 | -45 |
| Free Cash Flow | -1,513 | -10,431 | -7,045 | -4,190 |